Literature DB >> 26647818

Tumor suppressive microRNA‑429 regulates cellular function by targeting VEGF in clear cell renal cell carcinoma.

Duqun Chen1, Yuchi Li2, Yifan Li1, Lu Jin1, Zhengming Su1, Zuhu Yu1, Shangqi Yang1, Xiangming Mao1, Yongqing Lai1.   

Abstract

Clear cell renal cell carcinoma (ccRCC) is the predominant and most aggressive type of kidney malignancy, however, the mechanism underlying its carcinogenesis remains to be elucidated. The present study aimed to determine the expression and function of microRNA (miR)‑429 in ccRCC carcinogenesis. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) was used to detect the expression of miR‑429 in ccRCC specimens. Following transfection of miR‑429 synthetic mimics, the expression of miR‑429 was examined and cell proliferation, cell migration, apoptosis and luciferase assays were conducted in ccRCC cell lines. The results demonstrated that expression of miR‑429 was decreased in ccRCC cells. In addition, upregulation of miR‑429 by transfection of mimics reduced cellular proliferation and migration, and induced apoptosis in ACHN and 786‑0 cell lines. Furthermore, miR‑429 decreased the 3'UTR luciferase activity of vascular endothelial growth factor (VEGF) and c‑MYC, and RT‑qPCR analysis demonstrated that the cancer cells transfected with miR‑429 mimics exhibited decreased expression of VEGF, but not c‑MYC. To the best of our knowledge, the present study was the first to reveal that downregulated miR‑429 functioned as a tumor suppressor by restraining cellular proliferation and migration, and inducing apoptosis, as well as targeting VEGF in ccRCC cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26647818     DOI: 10.3892/mmr.2015.4653

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Soft-shelled turtle peptide modulates microRNA profile in human gastric cancer AGS cells.

Authors:  Yi-Chen Wu; Xiang Liu; Jiu-Li Wang; Xiang-Liu Chen; Lan Lei; Jing Han; You-Shui Jiang; Zhi-Qiang Ling
Journal:  Oncol Lett       Date:  2017-12-27       Impact factor: 2.967

2.  MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma.

Authors:  Zhengming Su; Ganggang Jiang; Jinlan Chen; Xing Liu; Haibo Zhao; Zhiyuan Fang; Yongzhong He; Xianhan Jiang; Guibin Xu
Journal:  Mol Clin Oncol       Date:  2019-10-25

3.  VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis.

Authors:  Chandran S Abhinand; Rajesh Raju; Sasikumar J Soumya; Prabha S Arya; Perumana R Sudhakaran
Journal:  J Cell Commun Signal       Date:  2016-09-12       Impact factor: 5.782

4.  [Inhibitory effect of miR-429 on expressions of ZO-1, Occludin, and Claudin-5 proteins to improve the permeability of blood spinal cord barrier in vitro].

Authors:  Rui Sun; Deshui Yu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-09-15

5.  MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.

Authors:  Liangyu Chen; Yixue Xue; Jian Zheng; Xiaobai Liu; Jing Liu; Jiajia Chen; Zhen Li; Zhuo Xi; Hao Teng; Ping Wang; Libo Liu; Yunhui Liu
Journal:  Front Mol Neurosci       Date:  2018-02-07       Impact factor: 5.639

6.  Bioinformatic gene analysis for possible biomarkers and therapeutic targets of hypertension-related renal cell carcinoma.

Authors:  Wenjie Huang; Ke Wu; Ruoyu Wu; Zhiguo Chen; Wei Zhai; Junhua Zheng
Journal:  Transl Androl Urol       Date:  2020-12

7.  Estradiol mediates the interaction of LINC01541 and miR-429 to promote angiogenesis of G1/G2 endometrioid adenocarcinoma in-vitro: A pilot study.

Authors:  Dan Qiao; Xiaoduo Qin; Haiyan Yang; Xuantong Liu; Libing Liu; Sufen Liu; Zhongzhi Jia
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

8.  MiR-367 regulates cell proliferation and metastasis by targeting metastasis-associated protein 3 (MTA3) in clear-cell renal cell carcinoma.

Authors:  Dexin Ding; Yue Zhang; Lin Wen; Jiangbo Fu; Xue Bai; Yuhua Fan; Yuan Lin; Hongshuang Dai; Qiang Li; Yong Zhang; Ruihua An
Journal:  Oncotarget       Date:  2017-06-27

9.  Low expression of miR-138 inhibit the proliferation, migration and invasion of colorectal cancer and affect patient survival by targeting SIRT1.

Authors:  Xianwu Kang; Bin Kong; Qiang Chen; Shipeng Zhao
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.